COMP <GO>
ILMN vs HUM // EV/EBITDA & P/E VALUATION
Illumina Inc. (NASDAQ) VS. Humana Inc. (NYSE) • 15-METRIC TALLY: ILMN 8
— HUM 5
▲ EV/EBITDA & P/E VALUATION LEADER: HUM
LAST: $235.99 (-18.64%) • MKT CAP: $43.80B
valuation
47.5x
LAST: $414.50 (-0.73%) • MKT CAP: $50.14B
valuation
18.4x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ILMN VS. HUM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ILMN | HUM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 66.10% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 18.20% | 8.30% | +9.90 | ILMN | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 47.5x | 18.4x | +29.10 | HUM | /valuation <GO> |
| Free Cash Flow Yield | 2.13% | 0.75% | +1.38 | ILMN | /fcf-yield <GO> |
| Operating Margin | 18.60% | 2.10% | +16.50 | ILMN | /operating-margins <GO> |
| Net Profit Margin | 19.60% | 0.90% | +18.70 | ILMN | /net-margins <GO> |
| Revenue Growth (YoY) | -0.70% | 10.10% | -10.80 | HUM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.86% | -0.86 | HUM | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 9.52 | 5.03 | +4.49 | ILMN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | ILMN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.1 | 53.9 | +3.20 | ILMN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.16 | 0.88 | +0.28 | ILMN | /macro-sensitivity <GO> |
| Forward P/E Multiple | 47.9x | 39.2x | +8.70 | HUM | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $43.80B | $50.14B | -$6.34B | HUM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ILMN REV | HUM REV | ILMN GROSS % | HUM GROSS % | ILMN FCF | HUM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.34B | $129.66B | 66.1% | — | $931.0M | $375.0M |
| FY 2024 | $4.37B | $117.76B | 65.4% | — | $709.0M | $2.39B |
| FY 2023 | $4.50B | $106.37B | — | — | $275.3M | -$805.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ILMN // BETA 1.16
HUM // BETA 0.88